GPCR logo

Structure Therapeutics Inc. (GPCR) EBITDA

Annual EBITDA:

-$157.24M-$54.76M(-53.43%)
December 31, 2024

Summary

  • As of today, GPCR annual EBITDA is -$157.24 million, with the most recent change of -$54.76 million (-53.43%) on December 31, 2024.
  • During the last 3 years, GPCR annual EBITDA has fallen by -$119.61 million (-317.91%).
  • GPCR annual EBITDA is now -888.53% below its all-time high of -$15.91 million, reached on December 1, 2020.

Performance

1-Year Change

-53.43%

3-Year Change

-317.91%

5-Year Change

-888.53%

15-Year Change

-888.53%

GPCR EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

10.68%
GPCR annual EBITDA is higher than 10.68% of companies in Healthcare sector

Range

All-Time High

-$15.91M
GPCR annual EBITDA is currently -888.53% below its historical high of -$15.91 million

3-Year Low

-$157.24M
GPCR annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
GPCR previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
GPCR next annual earnings announcement has not yet been scheduled

OtherGPCRincome statement metrics

Annual Revenue

$0.00
GPCR annual revenue is $0.00

Annual Net Income

-$122.59M
GPCR annual net profit is -$122.59 million

Annual EBIT

-$158.23M
GPCR annual earnings before interest & taxes is -$158.23 million

Annual EPS

-$2.33
GPCR annual earnings per share is -$2.33

Quarterly EBITDA:

-$70.16M-$14.12M(-25.20%)
June 30, 2025

Summary

  • As of today, GPCR quarterly EBITDA is -$70.16 million, with the most recent change of -$14.12 million (-25.20%) on June 30, 2025.
  • Over the past year, GPCR quarterly EBITDA has dropped by -$37.08 million (-112.07%).
  • GPCR quarterly EBITDA is now -444.64% below its all-time high of -$12.88 million, reached on March 1, 2022.

Performance

3-Month Change

-25.2%

1-Year Change

-112.07%

3-Year Change

-404.71%

5-Year Change

-431.19%

GPCR Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

5.32%
GPCR quarterly EBITDA is higher than 5.32% of companies in Healthcare sector

Range

All-Time High

-$12.88M
GPCR quarterly EBITDA is currently -444.64% below its historical high of -$12.88 million

3-Year Low

-$70.16M
GPCR quarterly EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2025
GPCR previous earnings announcement was published on Jun 30, 2025

Next Quarterly Earnings Report Date

Nov 10, 2025
GPCR next earnings announcement is scheduled for Nov 10, 2025

OtherGPCRincome statement metrics

Quarterly Revenue

$0.00
GPCR quarterly revenue is $0.00

Quarterly Net Income

-$61.88M
GPCR quarterly net profit is -$61.88 million

Quarterly EBIT

-$70.45M
GPCR quarterly earnings before interest & taxes is -$70.45 million

Quarterly EPS

-$1.08
GPCR quarterly earnings per share is -$1.08

TTM EBITDA:

-$218.56M-$37.08M(-20.43%)
June 30, 2025

Summary

  • As of today, GPCR TTM EBITDA is -$218.56 million, with the most recent change of -$37.08 million (-20.43%) on June 30, 2025.
  • Over the past year, GPCR TTM EBITDA has dropped by -$96.69 million (-79.34%).
  • GPCR TTM EBITDA is now -1554.72% below its all-time high of -$13.21 million, reached on December 1, 2021.

Performance

3-Month Change

-20.43%

1-Year Change

-79.34%

3-Year Change

-446.51%

5-Year Change

-1554.72%

GPCR TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

6.57%
GPCR TTM EBITDA is higher than 6.57% of companies in Healthcare sector

Range

All-Time High

-$13.21M
GPCR TTM EBITDA is currently -1554.72% below its historical high of -$13.21 million

3-Year Low

-$218.56M
GPCR TTM EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2025
GPCR previous earnings announcement was published on Jun 30, 2025

Next Quarterly Earnings Report Date

Nov 10, 2025
GPCR next earnings announcement is scheduled for Nov 10, 2025

OtherGPCRincome statement metrics

TTM Revenue

$0.00
GPCR TTM revenue is $0.00

TTM Net Income

-$179.38M
GPCR TTM net profit is -$179.38 million

TTM EBIT

-$219.66M
GPCR TTM earnings before interest & taxes is -$219.66 million

TTM EPS

-$3.13
GPCR TTM earnings per share is -$3.13

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$157.24M
GPCR annual EBITDA is -$157.24 million

Annual Net Income

-$122.59M
GPCR annual net profit is -$122.59 million

Annual Interest Expense

$0.00
GPCR annual interest expense is $0.00

Annual Income Tax

$310.00K
GPCR annual income tax is $310.00 thousand

Annual D&A

$992.00K
GPCR annual D&A is $992.00 thousand

GPCR EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-53.4%-112.1%-79.3%
3Y3 Years-317.9%-404.7%-446.5%
5Y5 Years-888.5%-431.2%-1554.7%

GPCR EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-317.9%at low-444.6%at low-451.0%at low
5Y5-Year-888.5%at low-444.6%at low-1554.7%at low
All-TimeAll-Time-888.5%at low-444.6%at low-1554.7%at low

GPCR EBITDA History

DateAnnualQuarterlyTTM
Jun 2025
-
-$70.16M(-25.2%)
-$218.56M(-20.4%)
Mar 2025
-
-$56.04M(-19.8%)
-$181.48M(-15.4%)
Dec 2024
-$157.24M(-53.4%)
-$46.79M(-2.7%)
-$157.24M(-11.2%)
Sep 2024
-
-$45.57M(-37.7%)
-$141.37M(-16.0%)
Jun 2024
-
-$33.08M(-4.1%)
-$121.86M(-6.3%)
Mar 2024
-
-$31.79M(-2.8%)
-$114.69M(-11.9%)
Dec 2023
-$102.48M
-$30.92M(-18.6%)
-$102.48M(-21.4%)
Sep 2023
-
-$26.07M(-0.6%)
-$84.44M(-44.7%)
DateAnnualQuarterlyTTM
Jun 2023
-
-$25.91M(-32.4%)
-$58.38M(-25.9%)
Mar 2023
-
-$19.58M(-52.0%)
-$46.36M(-16.9%)
Dec 2022
-$52.28M(-39.0%)
-$12.88M(+7.3%)
-$39.67M(+0.8%)
Jun 2022
-
-$13.90M(-7.9%)
-$39.99M(-53.3%)
Mar 2022
-
-$12.88M(+2.5%)
-$26.09M(-97.5%)
Dec 2021
-$37.62M(-136.5%)
-
-
Dec 2021
-
-$13.21M
-$13.21M
Dec 2020
-$15.91M
-
-

FAQ

  • What is Structure Therapeutics Inc. annual EBITDA?
  • What is the all-time high annual EBITDA for Structure Therapeutics Inc.?
  • What is Structure Therapeutics Inc. annual EBITDA year-on-year change?
  • What is Structure Therapeutics Inc. quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Structure Therapeutics Inc.?
  • What is Structure Therapeutics Inc. quarterly EBITDA year-on-year change?
  • What is Structure Therapeutics Inc. TTM EBITDA?
  • What is the all-time high TTM EBITDA for Structure Therapeutics Inc.?
  • What is Structure Therapeutics Inc. TTM EBITDA year-on-year change?

What is Structure Therapeutics Inc. annual EBITDA?

The current annual EBITDA of GPCR is -$157.24M

What is the all-time high annual EBITDA for Structure Therapeutics Inc.?

Structure Therapeutics Inc. all-time high annual EBITDA is -$15.91M

What is Structure Therapeutics Inc. annual EBITDA year-on-year change?

Over the past year, GPCR annual EBITDA has changed by -$54.76M (-53.43%)

What is Structure Therapeutics Inc. quarterly EBITDA?

The current quarterly EBITDA of GPCR is -$70.16M

What is the all-time high quarterly EBITDA for Structure Therapeutics Inc.?

Structure Therapeutics Inc. all-time high quarterly EBITDA is -$12.88M

What is Structure Therapeutics Inc. quarterly EBITDA year-on-year change?

Over the past year, GPCR quarterly EBITDA has changed by -$37.08M (-112.07%)

What is Structure Therapeutics Inc. TTM EBITDA?

The current TTM EBITDA of GPCR is -$218.56M

What is the all-time high TTM EBITDA for Structure Therapeutics Inc.?

Structure Therapeutics Inc. all-time high TTM EBITDA is -$13.21M

What is Structure Therapeutics Inc. TTM EBITDA year-on-year change?

Over the past year, GPCR TTM EBITDA has changed by -$96.69M (-79.34%)
On this page